Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ICAD Icad Inc
- Stocks
- Healthcare
- NASDAQ: ICAD
Price (delayed)
$3.91
Market cap
$107.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.2
Enterprise value
$87.59M
iCAD Inc., headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection and workflow solutions to support detection
Highlights
The debt has decreased by 41% YoY and by 15% from the previous quarter
The gross profit has increased by 9% year-on-year
The net income has plunged by 128% YoY but it has grown by 7% from the previous quarter
The company's EPS has shrunk by 122% YoY but it rose by 4.8% QoQ
Key stats
What are the main financial stats of ICAD
Market
Valuations
Earnings
Shares outstanding
27.45M
Market cap
$107.31M
Enterprise value
$87.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.48
Price to sales (P/S)
5.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.49
Revenue
$19.53M
Gross profit
$16.71M
Operating income
-$5.96M
Net income
-$5.23M
EBIT
-$5.12M
EBITDA
-$4.34M
Free cash flow
-$3.28M
Per share
Balance sheet
Liquidity
EPS
-$0.2
EPS diluted
-$0.2
Free cash flow per share
-$0.12
Book value per share
$1.13
Revenue per share
$0.73
TBVPS
$1.16
Total assets
$39.47M
Total liabilities
$8.68M
Debt
$307,000
Equity
$30.79M
Working capital
$20.43M
Debt to equity
0.01
Current ratio
3.66
Quick ratio
3.47
Net debt/EBITDA
4.55
Margins
Efficiency
Dividend
EBITDA margin
-22.2%
Gross margin
85.6%
Net margin
-26.8%
Operating margin
-30.5%
Return on assets
-13.7%
Return on equity
-17.5%
Return on invested capital
-127.7%
Return on capital employed
-16.1%
Return on sales
-26.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ICAD stock price
How has the Icad stock price performed over time
Intraday
-0.51%
1 week
8.61%
1 month
114.84%
1 year
147.47%
YTD
113.66%
QTD
89.81%
Financial performance
How have Icad's revenue and profit performed over time
Revenue
$19.53M
Gross profit
$16.71M
Operating income
-$5.96M
Net income
-$5.23M
Gross margin
85.6%
Net margin
-26.8%
The net income has plunged by 128% YoY but it has grown by 7% from the previous quarter
The net margin has plunged by 109% YoY but it has increased by 6% from the previous quarter
The gross profit has increased by 9% year-on-year
ICAD's revenue is up by 9% YoY
Price vs fundamentals
How does ICAD's price correlate with its fundamentals
Growth
What is Icad's growth rate over time
Valuation
What is Icad stock price valuation
P/E
N/A
P/B
3.48
P/S
5.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.49
The company's EPS has shrunk by 122% YoY but it rose by 4.8% QoQ
ICAD's price to book (P/B) is 132% higher than its last 4 quarters average of 1.5 but 6% lower than its 5-year quarterly average of 3.7
The equity has grown by 7% from the previous quarter but it has contracted by 5% YoY
ICAD's P/S is 133% above its last 4 quarters average of 2.3 and 9% above its 5-year quarterly average of 4.9
ICAD's revenue is up by 9% YoY
Efficiency
How efficient is Icad business performance
Icad's return on assets has shrunk by 158% YoY but it has increased by 6% QoQ
The ROE has plunged by 143% YoY but it has grown by 5% from the previous quarter
The company's return on sales has shrunk by 108% YoY but it rose by 7% QoQ
ICAD's return on invested capital is down by 7% since the previous quarter
Dividends
What is ICAD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ICAD.
Financial health
How did Icad financials performed over time
The current ratio has contracted by 22% YoY but it has grown by 4.6% from the previous quarter
Icad's quick ratio has decreased by 20% YoY but it has increased by 7% from the previous quarter
The debt is 99% less than the equity
The debt to equity has dropped by 50% year-on-year
The debt has decreased by 41% YoY and by 15% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.